Видео ютуба по тегу Jonathan Barratt

Fundamentals Of Silver Positive, But Likely To See A Correction: Jonathan Barratt Of ETO Markets
Fundamentals Of Silver Positive, But Likely To See A Correction: Jonathan Barratt Of ETO Markets
IgA Nephropathy Care: A Shift Toward Proactive, Targeted Treatment
IgA Nephropathy Care: A Shift Toward Proactive, Targeted Treatment
Examining Key Factors in IgAN: The Role of B Cells and BAFF/APRIL
Examining Key Factors in IgAN: The Role of B Cells and BAFF/APRIL
Промежуточные результаты исследования мезагитамаба для лечения IgA-нефропатии
Промежуточные результаты исследования мезагитамаба для лечения IgA-нефропатии
Business Property Relief: changes from 2026
Business Property Relief: changes from 2026
The ASN 2025 Clinical Snapshot: Catch Up With the Latest in IgAN and the B-Cell Pathway
The ASN 2025 Clinical Snapshot: Catch Up With the Latest in IgAN and the B-Cell Pathway
Большая «С» | Нефть и металлы: спрос, предложение и ценовые тенденции | Питер Макгуайр | Джонатан...
Большая «С» | Нефть и металлы: спрос, предложение и ценовые тенденции | Питер Макгуайр | Джонатан...
Highlights from the 18th International IgA Nephropathy Symposium (IIgANN 2025), Prague
Highlights from the 18th International IgA Nephropathy Symposium (IIgANN 2025), Prague
IgA Nephropathy an Update 2025
IgA Nephropathy an Update 2025
IgA-NP: Treatment Standard & Future Perspective - Prof. Jonathan Barratt, Prof. Jai Radhakrishnan
IgA-NP: Treatment Standard & Future Perspective - Prof. Jonathan Barratt, Prof. Jai Radhakrishnan
Optimizing IgAN Care: Achieving Lower Proteinuria Targets with Combination Therapy
Optimizing IgAN Care: Achieving Lower Proteinuria Targets with Combination Therapy
«Индия — это светлый пятно»: Джонатан Барратт о причинах роста иностранных инвестиционных фондов ...
«Индия — это светлый пятно»: Джонатан Барратт о причинах роста иностранных инвестиционных фондов ...
Jonathan Barratt-Peacock - 18th Jan 2025
Jonathan Barratt-Peacock - 18th Jan 2025
IgA Nephropathy Care: A Shift Toward Proactive, Targeted Treatment
IgA Nephropathy Care: A Shift Toward Proactive, Targeted Treatment
Precious Metals Shine: Gold and Silver Rally on Safe-Haven Demand | Jonathan Barratt Analyses
Precious Metals Shine: Gold and Silver Rally on Safe-Haven Demand | Jonathan Barratt Analyses
Expect Silver Prices To Touch $49-50/oz Over The Next Couple Of Years: ETO Markets | CNBC TV18
Expect Silver Prices To Touch $49-50/oz Over The Next Couple Of Years: ETO Markets | CNBC TV18
The Big C | Is The Dollar Headed For Further Downturn? | CNBC TV18
The Big C | Is The Dollar Headed For Further Downturn? | CNBC TV18
Jonathan Barratt On India-US Trade Deal, China's Russian Oil Imports & More | NDTV Profit
Jonathan Barratt On India-US Trade Deal, China's Russian Oil Imports & More | NDTV Profit
Trump Doubles Steel, Aluminum Tariffs To 50% | Jonathan Barratt Analyses The Tariff Impact On Trade
Trump Doubles Steel, Aluminum Tariffs To 50% | Jonathan Barratt Analyses The Tariff Impact On Trade
2025 update on what's happening in IgA Nephropathy
2025 update on what's happening in IgA Nephropathy
Jonathan Barratt On FII Flows In India, Moody's Downgrading US Credit, Dollar Index Dip & More
Jonathan Barratt On FII Flows In India, Moody's Downgrading US Credit, Dollar Index Dip & More
Targeted Disease Modification in IgA Nephropathy
Targeted Disease Modification in IgA Nephropathy
Jonathan Barratt On US-China Trade Deal, FII Inflows, Crude Prices & More | Stock Market Updates
Jonathan Barratt On US-China Trade Deal, FII Inflows, Crude Prices & More | Stock Market Updates
Why Did OPEC+ Increase Crude Oil Production Amid Price Fall? | Jonathan Barratt Decodes The Impact!
Why Did OPEC+ Increase Crude Oil Production Amid Price Fall? | Jonathan Barratt Decodes The Impact!
A Turnaround In The Chinese Economy Would Be Supportive For Gold: ETO Markets | CNBC TV18
A Turnaround In The Chinese Economy Would Be Supportive For Gold: ETO Markets | CNBC TV18